(i) Philogen will give a poster presentation about the phase II study of Daromun (Nidlegy) for the treatment of non-melanoma skin cancer -
(ii) Study shows promising early signs of efficacy in patients with basal cell carcinoma
A Brigadier General, Neurosurgeon, Critical Care Specialist and a PhD Team Up With Business and Technology Executives to Help Businesses Navigate COVID-19 Testing to Re-Enter the American Economy
SUGENTECH's COVID-19 IgM&IgG 5-10 minutes rapid test kit is listed on the U.S. FDA's database and can be used in the U.S., as stated in Section IV.D of the FDA's Policy for Diagnostic Tests for Coronavirus Disease-2019, and is planning to go further to seek EUA from U.S. FDA.
Read MoreR-Pharm and GenQual are pleased to announce a new collaboration focused on the development of novel predictive diagnostic tools in the area of Rheumatoid Arthritis and Autoimmune diseases.
Read MoreCreative Diagnostics announced the key service in this month in its official website. It is not unexpected that Hamster Monoclonal Antibody Production become the key service for its good comments from the customers.
Read MoreCreative Diagnostics is planning to partner with university in New York the Master of BioChemical Sciences Program and the partnership will offer work experience for graduate students.
Read MoreGeoVax has decided to expand its preventative HIV/AIDS vaccine development effort in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health (NIH) and the HIV Vaccine Trials
Read MoreNovus Biologicals, a leading international supplier of high quality antibodies and proteins to the bioresearch industry, is pleased to announce the introduction of a new range of Beta Amyloid antibodies to their antibody catalogue.
Read MoreAnaSpec introduces the Speedy 28-day custom polyclonal antibody service. Leveraging proven technology from Eurogentec, AnaSpec's parent company, this protocol uses a proprietary mixture of Freund's free immuno-stimulatory compounds.
Read MoreCardioGenics Extends its Partnership with Merck Chimie by Entering into a Second Agreement to Link Biological Material to Merck Chimie's Magnetic Particles for Antibody Manufacturing: Deal Deepens Company's Involvement In Merck's Magnetic Bead
Read More